Tue 14 Jan, 2025 – 12:48 ET
Ache Laboratorios Farmaceuticos S.A.’s (Ache; BB+/Stable) Negative Outlook on the LongTerm (LT) Local Currency (LC) Issuer Default Rating (IDR) continues to reflect the increasing difficulty in recovering EBITDA margins and preserving market share amid a competitive environment. Ache’s LT Foreign Currency (FC) IDR is capped by Brazil’s Country Ceiling of ‘BB+’, as its operations are concentrated in Brazil. Ache’s ratings reflect its strong business position in the defensive Brazilian pharmaceutical retail market, with leadership in the prescription segment, and strong and well-established brands with pricing premiums.
Fonte: Fitch Ratings